Yan Qin

402 total citations
13 papers, 124 citations indexed

About

Yan Qin is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Yan Qin has authored 13 papers receiving a total of 124 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Yan Qin's work include Ferroptosis and cancer prognosis (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and RNA modifications and cancer (2 papers). Yan Qin is often cited by papers focused on Ferroptosis and cancer prognosis (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and RNA modifications and cancer (2 papers). Yan Qin collaborates with scholars based in China, Canada and Spain. Yan Qin's co-authors include Xiaozhen Li, Ying Fu, Jun Liu, Jie Yang, Lihua Zhang, Wei Li, Xiaoying Wei, Qiuyun Li, Tianyu Qin and Huawei Yang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Frontiers in Immunology.

In The Last Decade

Yan Qin

13 papers receiving 124 citations

Peers

Yan Qin
Comparison fields: 5 of 53
  • Molecular Biology 56
  • Pulmonary and Respiratory Medicine 31
  • Cancer Research 29
  • Oncology 27
  • Immunology 26
Replace Yi Dong with:
Yi Dong China
Konstantinos Vanezis United Kingdom
Arnaud Chignon Canada
Yue Hou China
Fernando Abollo‐Jiménez Spain
Ninad Oak United States
Momin Ahmed United Kingdom
Griet Vanpoucke United Kingdom
Amanda Dalby United Kingdom
Loreall Pooler United States
Yi Dong China View profile →
Citations per field, relative to Yan Qin
Yan Qin · 1×
Citations per year, relative to Yan Qin
Yan Qin · 1×

Countries citing papers authored by Yan Qin

Since Specialization
Citations

This map shows the geographic impact of Yan Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Qin more than expected).

Fields of papers citing papers by Yan Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Qin. The network helps show where Yan Qin may publish in the future.

Co-authorship network of co-authors of Yan Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Qin. A scholar is included among the top collaborators of Yan Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Qin. Yan Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
# Work Indexed citations
1 2
2 7
3 7
4 3
5 2
6
GIMAP7 as a Potential Predictive Marker for Pan-Cancer Prognosis and Immunotherapy Efficacy
12
7 43
8 13
9 6
10 8
11 6
12 11
13 4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026